Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Psychol Health Med. 2018 Jun 14;23(10):1182–1195. doi: 10.1080/13548506.2018.1476723

Table 1.

Sample Characteristics.

Variable Statistic
M SD
Age 41–88 65.33 9.17
Comorbidities 1–9 3.4 1.87
Combat PTSD symptoms 0–4 0.59 1.27
Treatment length 1–18 6.84 5.93
PROMIS Social Role Interference (T1) 4–20 13.05 5.21
PROMIS Pain Interference (T1) 4–20 8.14 5.18
n %
Education High school or less 57 46.7
College (some or graduate) 65 53.3
Race African American and other 25 20.5
Caucasian 97 79.5
Cancer Type Head and Neck 42 34.4
Colorectal 71 58.2
Eso-gastric 9 7.4
Cancer Stage Stage I 34 27.9
Stage II 35 28.7
Stage III 29 23.8
Stage IV 24 19.7
Treatment Type Surgery 96 78.7
Chemotherapy 68 55.7
Radiation 46 37.7
Previous MH Treatment Yes 44 36.1

Note. Combat PTSD = Primary Care PTSD Screen; PROMIS = Patient-Reported Outcomes Measurement Information System.